NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

TB & Outbreaks Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB & Outbreaks Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Escherichia Coli



Recent studies from University of Edinburgh add new data to Escherichia coli



January 20th, 2009

According to recent research from Scotland, "Non-sorbitol-fermenting (NSF) Escherichia coli O157: H7 is the primary Shiga toxin-producing E. coli (STEC) serotype associated with human infection. Since 1988, sorbitol-fermenting (SF) STEC O157: NM strains have emerged and have been associated with a higher incidence of progression to hemolytic-uremic syndrome (HUS) than NSF STEC O157: H7."

"This study investigated bacterial factors that may account for the increased pathogenic potential of SF STEC O157: NM. While no evidence of toxin or toxin expression differences between the two O157 groups was found, the SF STEC O157: NM strains adhered at significantly higher levels...


Source: TB & Outbreaks Week (2009-01-20)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login